Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Videos | Antiplatelet and Anticoagulation Therapies
VIDEO: Use of Shorten DAPT and the Xience Stent in High-bleeding Risk Patients

Roxana Mehran, M.D., and Marco Valgimiggle, M.D., present the results of the Xience 90/28 trials that evaluated the use ...

Home October 19, 2020
Home
A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab
No Mortality Risk Associated With Paclitaxel-coated Devices Used to Treat Peripheral Artery Disease

October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit ...

Home October 18, 2020
Home
Videos | Cath Lab
VIDEO: Pre-emptive Treatment of Vulnerable Plaques With Bioresorbable Stents

Gregg Stone, M.D., presents the results of the PROSPECT ABSORB Trial in a press conference at the 2020 ranscatheter ...

Home October 17, 2020
Home
The Abbott Vascular Xience Sierra drug eluting stent (DES). The XIENCE 28 and XIENCE 90 studies presented at TCT 2020 showed the stent can be used safely with only one month of dual antiplatelet therapy (DAPT). #TCT #TCTconnect #TCT2020
News | Stents Drug Eluting
Shorter DAPT With Xience Stent is Noninferior to Standard DAPT

October 16, 2020 – Results from the XIENCE 90/28 clinical trials have shown that a shorter course of dual-antiplatelet ...

Home October 16, 2020
Home
The FDA has cleared a new indication for the Medtronic Resolute Onyx Drug Eluting Stent, making it the first DES that only required one month of dual antiplatelet therapy (DAPT) in patients who are considered high risk for bleeding complications.
News | Stents
Medtronic Resolute Onyx Drug Eluting Stent First to Receive One-Month DAPT Indication

October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual ...

Home October 01, 2020
Home
The Opimax TiNO bio-active coated stent made by Hexacath.
News
Optimax Nitride-oxide Coated Stent Superior to Synergy Drug-eluting Stent in TIDES-ACS Trial

September 5, 2020 – The TIDES-ACS Randomized Controlled Trial results were published end of July 2020 confirming the ...

Home September 10, 2020
Home
The U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for the Boston Scientific Eluvia Drug-Eluting Vascular Stent System as part of the 2021 Inpatient Prospective Payment System (IPPS). 
News | Peripheral Artery Disease (PAD)
CMS Grants Additional Reimbursement for Eluvia Vascular Stent

September 4, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment ...

Home September 04, 2020
Home
Abbott Espirit BTK Bioresorbable stent, or bioresorbable vascular scaffold (BVS) measures 99 microns and is made from poly-L-lactide (PLLA), a semi-crystalline bioresorbable polymer engineered to resist vessel recoil and provide a platform for drug delivery. Abbott Absorb
Feature | Stents Bioresorbable
Abbott Restarts Bioresorbable Stent Clinical Trials With New Esprit Below-the-knee Scaffold

September 3, 2020 — Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and ...

Home September 03, 2020
Home
News | Stents
CeloNova Completes Enrollment of First Randomized 14-Day DAPT Trial For a Stent

July 24, 2020 — CeloNova BioSciences Inc. announced it successfully completed enrollment of the COBRA REDUCE randomized ...

Home July 24, 2020
Home
A carotid artery atherosclerotic plaque blockage at the bifurcation seen here can cause strokes. The stenting these lesions is a less invasive way of treating than open vessel surgery. The SVS has issued guidelines to help guide credentialing for the carotid stent procedure. Image from Vital Images.
News | Stroke
Society for Vascular Surgery Outlines What is Needed for Trans-Carotid Artery Revascularization Training and Credentialing

July 9, 2020 — The Society for Vascular Surgery (SVS) has released a clinical competence statement on training and ...

Home July 09, 2020
Home
he 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent showed low rates of revascularization and compared very favorably to current standards of care.  The results were presented by Professor Thomas Zeller, M.D., University Heart Centre Freiburg, Bad Krozingen, Germany at the CX 2020 Live conference.   
News | Peripheral Artery Disease (PAD)
Excellent 3-year Results in MIMICS-2 Study of the BioMimics 3D Vascular Stent 

June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent ...

Home June 16, 2020
Home
Coronary and Peripheral Stent Market Expected to Double Through 2025
News | Stents
Coronary and Peripheral Stent Market Expected to Double Through 2025

May 28, 2020 — The rising incidence of cardiovascular disease has prompted people to seek timely treatment to improve ...

Home May 28, 2020
Home
Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.
News | Robotic Systems
Hoag Performs First Robotic Carotid Artery Stenting on West Coast

May 28, 2020 — Hoag Memorial Hospital Presbyterian recently became the first hospital on the West Coast to perform an ...

Home May 28, 2020
Home
The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration. #SCAI2020
News | Stents
TWILIGHT Trial Substudy Examines Bioabsorbable Polymer vs. Durable Polymer Drug-Eluting Stents in High-Risk PCI

May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) ...

Home May 17, 2020
Home
Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the 2020 Cardiovascular Research Technologies (CRT) Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinforcing the differentiation of the Orsiro coronary drug-eluting stent (DES), which is the first DES to outperform Xience.
News | Stents
Biotronik's Orsiro Stent Continues Excellent Results After Three Years

February 24, 2020 — Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the ...

Home February 24, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now